NEW TAIPEI CITY, Taiwan, April 7, 2020 /PRNewswire/ -- COVID-19 is now characterized as a pandemic by WHO. A tremendous amount of fear and anxiety continues to impact large populations as a result of this unprecedented situation, in large part due to the confusion that results from the similarity in symptoms of COVID-19 and other infections. Fever, frequent coughing, and feelings of fatigue, for example, can appear as a result of both COVID-19 and Influenza. Because of this, it is vital to produce rapid tests that can identify infections on-site and same day.
COVID-19 Rapid Screening with Blood Samples
Many COVID-19 tests presently use RT-PCR with swab samples. However, this kind of detection method cannot meet community needs in the event of an infection breakout, due to time consuming operation processes and requirements for expensive laboratory equipment. Additionally, clinical studies demonstrate that COVID-19 tests should use both RNA detection (typical for quantitative RT-PCR tests) and antibody measurements from a patient's blood to provide a more accurate diagnosis . Fortunately, many test strip vendors have already developed rapid test kits which use blood samples to detect the antibody response against the SARS-CoV-2 virus within just 15 minutes.
Needless to say, for those anxious about contracting COVID-19, rapid-screening test kits are vital. Such tests allow individuals to make a preliminary confirmation as to whether their symptoms are indicative of influenza, COVID-19, or other infections. Here we offer a total solution for this unmet need by bundling Haiim, the vacuum assisted fingertip blood collection system developed by Winnoz Technology Inc, with various testing kits to identify COVID-19 infections. The rapid screening test results can help the medical staff to quickly identify the illness and proceed with appropriate treatments.
Several rapid screening tests have already been bundled with Haiim, these packages can be used by many communities worldwide, enabling fast and effective testing for illness, including COVID-19 and various flus for anyone, anywhere.
Furthermore, in order to expedite control of this epidemic, Haiim incorporates multiple different tests at once, which is extremely time-saving for communities impacted by the consequences of an unexpected outbreak.
It is our sincere hope for Haiim to contribute to the global fight against the corona virus.
 J. Zhao et al., Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019 (2020). Available at SSRN: https://ssrn.com/abstract=3546052
SOURCE WINNOZ TECHNOLOGY INC